Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.
In this episode of In Conversation, Dr. Tom Barber, professor of endocrinology and obesity expert, helps us explore the evidence linking a Mediterranean diet to a longer, healthier life.
